These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

940 related articles for article (PubMed ID: 32919977)

  • 1. Immunopathology of Hyperinflammation in COVID-19.
    Gustine JN; Jones D
    Am J Pathol; 2021 Jan; 191(1):4-17. PubMed ID: 32919977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm.
    Chau AS; Weber AG; Maria NI; Narain S; Liu A; Hajizadeh N; Malhotra P; Bloom O; Marder G; Kaplan B
    Arthritis Rheumatol; 2021 Jan; 73(1):23-35. PubMed ID: 32929876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Response in Severe and Non-Severe Coronavirus Disease 2019 (COVID-19) Infection: A Mechanistic Landscape.
    Mukund K; Nayak P; Ashokkumar C; Rao S; Almeda J; Betancourt-Garcia MM; Sindhi R; Subramaniam S
    Front Immunol; 2021; 12():738073. PubMed ID: 34721400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperinflammation and Immune Response Generation in COVID-19.
    Mishra KP; Singh AK; Singh SB
    Neuroimmunomodulation; 2020; 27(2):80-86. PubMed ID: 33341814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management.
    Anka AU; Tahir MI; Abubakar SD; Alsabbagh M; Zian Z; Hamedifar H; Sabzevari A; Azizi G
    Scand J Immunol; 2021 Apr; 93(4):e12998. PubMed ID: 33190302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology.
    Song NJ; Allen C; Vilgelm AE; Riesenberg BP; Weller KP; Reynolds K; Chakravarthy KB; Kumar A; Khatiwada A; Sun Z; Ma A; Chang Y; Yusuf M; Li A; Zeng C; Evans JP; Bucci D; Gunasena M; Xu M; Liyanage NPM; Bolyard C; Velegraki M; Liu SL; Ma Q; Devenport M; Liu Y; Zheng P; Malvestutto CD; Chung D; Li Z
    J Hematol Oncol; 2022 Jan; 15(1):5. PubMed ID: 35012610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.
    Al-Kuraishy HM; Al-Gareeb AI; Al-Hussaniy HA; Al-Harcan NAH; Alexiou A; Batiha GE
    Int Immunopharmacol; 2022 Mar; 104():108516. PubMed ID: 35032828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and Neutrophils: The Relationship between Hyperinflammation and Neutrophil Extracellular Traps.
    Borges L; Pithon-Curi TC; Curi R; Hatanaka E
    Mediators Inflamm; 2020; 2020():8829674. PubMed ID: 33343232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocytes and macrophages in COVID-19: Friends and foes.
    Meidaninikjeh S; Sabouni N; Marzouni HZ; Bengar S; Khalili A; Jafari R
    Life Sci; 2021 Mar; 269():119010. PubMed ID: 33454368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Understanding of the Innate Control of Toll-like Receptors in Response to SARS-CoV-2 Infection.
    Jung HE; Lee HK
    Viruses; 2021 Oct; 13(11):. PubMed ID: 34834939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
    Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
    EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR2 Signaling Restricts SARS-CoV-2 Infection.
    Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
    mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2-mediated immune system activation and potential application in immunotherapy.
    Tan Y; Tang F
    Med Res Rev; 2021 Mar; 41(2):1167-1194. PubMed ID: 33185926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.
    Merad M; Martin JC
    Nat Rev Immunol; 2020 Jun; 20(6):355-362. PubMed ID: 32376901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and HIV-Associated Immune Reconstitution Inflammatory Syndrome: Emergence of Pathogen-Specific Immune Responses Adding Fuel to the Fire.
    Seddiki N; French M
    Front Immunol; 2021; 12():649567. PubMed ID: 33841434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
    Boechat JL; Chora I; Morais A; Delgado L
    Pulmonology; 2021; 27(5):423-437. PubMed ID: 33867315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword.
    Tan LY; Komarasamy TV; Rmt Balasubramaniam V
    Front Immunol; 2021; 12():742941. PubMed ID: 34659238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathological Roles of Neutrophils in Virus Infection and COVID-19.
    Cui SN; Tan HY; Fan GC
    Shock; 2021 Sep; 56(3):345-351. PubMed ID: 33534399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model
    Bohländer F; Riehl D; Weißmüller S; Gutscher M; Schüttrumpf J; Faust S
    Front Immunol; 2021; 12():700429. PubMed ID: 34177967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.
    Pantazi I; Al-Qahtani AA; Alhamlan FS; Alothaid H; Matou-Nasri S; Sourvinos G; Vergadi E; Tsatsanis C
    Front Immunol; 2021; 12():683800. PubMed ID: 34248968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.